Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2013 1
2014 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.
Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, Frishman M, Gayed M, Hodson K, Khamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Schreiber K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Williams D, Yee CS, Gordon C, Giles I; BSR Standards, Audit and Guidelines Working Group. Russell MD, et al. Rheumatology (Oxford). 2023 Apr 3;62(4):e48-e88. doi: 10.1093/rheumatology/keac551. Rheumatology (Oxford). 2023. PMID: 36318966 Free PMC article. No abstract available.
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.
Ding T, Ledingham J, Luqmani R, Westlake S, Hyrich K, Lunt M, Kiely P, Bukhari M, Abernethy R, Bosworth A, Ostor A, Gadsby K, McKenna F, Finney D, Dixey J, Deighton C; Standards, Audit and Guidelines Working Group of BSR Clinical Affairs Committee; BHPR. Ding T, et al. Rheumatology (Oxford). 2010 Nov;49(11):2217-9. doi: 10.1093/rheumatology/keq249a. Epub 2010 Sep 12. Rheumatology (Oxford). 2010. PMID: 20837498 No abstract available.
BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.
Deighton C, Hyrich K, Ding T, Ledingham J, Lunt M, Luqmani R, Kiely P, Bukhari M, Abernethy R, Ostor A, Bosworth A, Gadsby K, McKenna F, Finney D, Dixey J; BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR. Deighton C, et al. Rheumatology (Oxford). 2010 Jun;49(6):1197-9. doi: 10.1093/rheumatology/keq006a. Epub 2010 Mar 22. Rheumatology (Oxford). 2010. PMID: 20308121 No abstract available.
BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.
Deighton C, Hyrich K, Ding T, Ledingham J, Lunt M, Luqmani R, Kiely P, Bukhari M, Abernethy R, Ostor A, Bosworth A, Gadsby K, McKenna F, Finney D, Dixey J; on behalf of BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR. Deighton C, et al. Rheumatology (Oxford). 2010 Mar 22. doi: 10.1093/rheumatology/keq006b. Online ahead of print. Rheumatology (Oxford). 2010. PMID: 20308120 No abstract available.
The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics.
Coates LC, Tillett W, Chandler D, Helliwell PS, Korendowych E, Kyle S, McInnes IB, Oliver S, Ormerod A, Smith C, Symmons D, Waldron N, McHugh NJ; BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR. Coates LC, et al. Rheumatology (Oxford). 2013 Oct;52(10):1754-7. doi: 10.1093/rheumatology/ket187. Epub 2013 Jul 25. Rheumatology (Oxford). 2013. PMID: 23887065 No abstract available.
The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis.
Malaviya AP, Ledingham J, Bloxham J, Bosworth A, Buch M, Choy E, Cope A, Isaacs J, Marshall D, Wright G, Ostör AJ; BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group; BHPR. Malaviya AP, et al. Rheumatology (Oxford). 2014 Jul;53(7):1344-6. doi: 10.1093/rheumatology/keu168. Epub 2014 May 12. Rheumatology (Oxford). 2014. PMID: 24821853 No abstract available.
Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.
Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, Frishman M, Gayed M, Hodson K, Khamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Schreiber K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Williams D, Yee CS, Gordon C, Giles I; BSR Standards, Audit and Guidelines Working Group. Russell MD, et al. Rheumatology (Oxford). 2023 Apr 3;62(4):1370-1387. doi: 10.1093/rheumatology/keac558. Rheumatology (Oxford). 2023. PMID: 36318965 Free PMC article. No abstract available.
British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice.
Schreiber K, Frishman M, Russell MD, Dey M, Flint J, Allen A, Crossley A, Gayed M, Hodson K, Khamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Williams D, Yee CS, Gordon C, Giles I; BSR Standards, Audit and Guidelines Working Group. Schreiber K, et al. Rheumatology (Oxford). 2023 Apr 3;62(4):e89-e104. doi: 10.1093/rheumatology/keac552. Rheumatology (Oxford). 2023. PMID: 36318967 Free PMC article. No abstract available.
Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice.
Schreiber K, Frishman M, Russell MD, Dey M, Flint J, Allen A, Crossley A, Gayed M, Hodson K, Khamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Williams D, Yee CS, Gordon C, Giles I; BSR Standards, Audit and Guidelines Working Group. Schreiber K, et al. Rheumatology (Oxford). 2023 Apr 3;62(4):1388-1397. doi: 10.1093/rheumatology/keac559. Rheumatology (Oxford). 2023. PMID: 36318970 Free PMC article. No abstract available.